drugset / Trial / NCT04576325
Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a Phase 1b, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and pharmacokinetic profiles of voriconazole inhalation powder in adult subjects with well-controlled asthma. This study will involve 2 cohorts.
Timeline
- Start
- 2020-11-15
- Primary completion
- 2021-11-12
- Completion
- 2021-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voriconazole | Small molecule | 40 mg | Inhaled |
| Subject | Voriconazole | Small molecule | 80 mg | Inhaled |